Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta. (2025). Life and Science, 6(4), 06. https://doi.org/10.37185/LnS.1.1.870